Jacobs Levy Equity Management, Inc Pulmonx Corp Transaction History
Jacobs Levy Equity Management, Inc
- $24.7 Billion
- Q3 2024
A detailed history of Jacobs Levy Equity Management, Inc transactions in Pulmonx Corp stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 301,361 shares of LUNG stock, worth $1.94 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
301,361
Previous 490,287
38.53%
Holding current value
$1.94 Million
Previous $3.11 Million
19.63%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding LUNG
# of Institutions
123Shares Held
31MCall Options Held
300Put Options Held
56.8K-
Primecap Management CO Pasadena, CA5.68MShares$36.6 Million0.04% of portfolio
-
Morgan Stanley New York, NY3.79MShares$24.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$17.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$14.7 Million0.0% of portfolio
-
Jefferies Group LLC New York, NY1.2MShares$7.75 Million0.2% of portfolio
About Pulmonx Corp
- Ticker LUNG
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,268,400
- Market Cap $240M
- Description
- Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...